Menu

rss
J NeuroIntervent Surg 4:314 doi:10.1136/neurintsurg-2012-010327
  • PostScript
  • Letters to the editor

Authors' response to Pipeline, aneurysms and the FDA

  1. David Fiorella2
  1. 1Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA
  2. 2Department of Neurosurgery, State University of New York, Stony Brook, New York, USA
  1. Correspondence to Dr David F Kallmes, Department of Radiology, Mayo Clinic, Rochester, Minnesota 55905, USA; kallmes.david{at}mayo.edu
  • Accepted 29 February 2012
  • Published Online First 20 March 2012

Keywords:

We greatly appreciate the input by Dr Hirsch and colleagues.1 Our paper was a highly-focused empirical exercise to determine, based on morphology alone, the potential for endoluminal implants for treatment of aneurysms. There are myriad additional factors that, without question, will affect the appropriateness of …

[Full text of this article]

Related Article

  • New devices: Estimating the proportion of intracranial aneurysms likely to be amenable to treatment with the pipeline embolization device
    • Waleed Brinjikji,
    • Harry J Cloft,
    • David Fiorella,
    • Giuseppe Lanzino,
    • David F Kallmes
    J NeuroIntervent Surg 2013;5:1 45-48 Published Online First: 2 December 2011 doi:10.1136/neurintsurg-2011-010165

This Article

  1. Extract
  2. Full text
  3. PDF
  4. All Versions of this Article:
    1. neurintsurg-2012-010327v1
    2. 4/4/314-a most recent

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

 

Access to JNIS


The Journal of NeuroInterventional Surgery forms part of the subscription to JNNP for both institutions and individuals. Individuals may subscribe separately to JNIS in print and/or Online: Subscribe here

SNIS members receive JNIS in print and can access the journal online via the members' area of the SNIS website

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



SNIS logo